Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
Heejoon JangSu Jong YuMark Hong LeeTae Min KimYun Bin LeeEun-Ju ChoJeong-Hoon LeeJung Hwan YoonYun Joon KimPublished in: Journal of Korean medical science (2023)
ClinicalTrials.gov Identifier: NCT02585947.